Clinical Trials Directory

Trials / Sponsors / Chongqing Peg-Bio Biopharm Co., Ltd.

Chongqing Peg-Bio Biopharm Co., Ltd.

Industry · 8 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chro
Thrombocytopenia Associated With Chronic Liver Disease
Phase 1 / Phase 22025-06-06
RecruitingStudy of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Primary Immune Thrombocytopenia (ITP)
Phase 12025-03-07
RecruitingEfficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
Short Bowel Syndrome
Phase 32024-09-03
CompletedA Study of FT1 in Healthy Adult Volunteers
Diarrhea Caused by Drug (Disorder)
Phase 12024-08-20
CompletedA Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patient
Thrombocytopenia
Phase 12023-12-06
CompletedA Study of PD5K3 in Healthy Adult Volunteers
Lymphoblastic Leukemia, Acute, Lymphoblastic Lymphoma
Phase 12023-11-27
CompletedA Study of PJ009 in Healthy Adult Volunteers
Short Bowel Syndrome
Phase 12023-02-28
CompletedA Study of PN20 in Healthy Adult Volunteers
Chemotherapy-induced Thrombocytopenia, Immune Thrombocytopenic Purpura
Phase 12022-06-16